Abstract. Since the first description of the movement of blood around the body by William Harvey, the accurate measurement of blood velocity has provided a major challenge for medical science. This review looks at the contribution made by techniques using radioactive tracers. lnitiauy considedon is given to the fundamental problem of how to measure the mount of tadidracer in an organ with sufficient accuracy. using both single-photon and positron-emitting tracers. The various models used to link tracer behaviour with blood flow are fhen discussed and the article closes with a detailed review of the clinical applications of blood flow measurements.
Introduction

The historical background
'. . . the blood is passed through the lungs and heart by the pulsation of the ventricles, is forcibly ejected to all parts of the body, therein steals into the veins and porosities of the flesh.. .' (Harvey 1628) .
Since the elucidation of the movement of blood by William Harvey in 1628, the accurate measurement of blood velocity has provided a major challenge for medical science. The earliest documented measurements were by Hales in 1733 who computed the blood flow in the aorta of a horse. Using an estimation of the capacity of the left ventricle, the diameter of the base of the aorta and the pulse rate, he arrived at a value of 8952 feet per hour.
While early studies used chemical tracers, the first recorded application of a radioactive tracer was by Blumgmt and Yens in 1927. Radium C deposited on sodium chloride and then dissolved in sterile distilled water was injected into one arm and its time of arrival in the other arm recorded by a Wilson cloud chamber. In patients with a normal cardiorespiratory system, this transit time ranged from 15 to 21 s, while in those with cardiac conditions, it varied from 50 to 65 s.
This early tracer work simply involved measuring the temporal difference between injection and the arrival of the tracer at a second point. It ignored the effect of the dilution of the tracer as this required a detector able to provide quantitative information on the amount of radioactivity present. The so-called indicator-dilution approach, developed by Kety and Schmidt (1945, 1948) , measured flow by observing the time course of a tracer concentration in arterial and venous blood, nitrous oxide being used as the tracer. The potential of radioactivity to permit the direct measurement of tracer concentration in tissue was first proposed by Smith and Quimby (1945) who used intravenously injected =Na to measure peripheral blood flow in terms of the rate of build-up of activity at the measurement site. Kety, also using =Na, studied muscle blood flow and was me first to appreciate the value of studying the clearance of the tracer when it had been injected at the measurement site rather than intravenously. However, he did not go so far as to equate clearance-rate measurement with blood flow.
From this time the use of radioactive tracers to measure blood flow progressed with the development of new tracers, instrumentation capable of measuring the concentration of tracer, and models to describe tracer Idnetics. Undoubtedly, the tracer that has made the greatest impact is xenon. It was iirst suggested by Conn (1955) for the measurement of blood flow in brain, muscle, and liver in dogs, and first applied to humans by Glass and Harper (1963) to assess brain blood flow. But it has been the Copenhagen group, under Neils Lassen, that has demonstrated the full potential of this tracer for measuring organ blood flow.
With the development of positron-emission tomography (PET) a new range of tracers became available. So far as blood flow was concemed, the most important tracer has been radiolabelled water, but, as for xenon, the complexity of the technique, using apparatus available only in major centres, has limited the development for routine clinical measurement of blood flow. A significant step forward in recent years has been the introduction of cerebral-blood-flow tracers, in particular 99Tcm HM-PAO, that can be imaged with singlephoton-emission computed tomography (SPECT) , thus giving a technique that, while not readily capable of providing quantitative measures of flow, can be performed in most nuclear-medicine centres.
The definition of bloodflow
The most common measure of blood flow is the total flow rate, F , to an organ in units of volume per unit time, usually millilitres per minute. However, as mentioned in subsection 1.1, it is frequently simpler to measure the time taken for a tracer to pass from the inflow to the outaow of the organ, the so-called transit time. Accepting that any flow measure is a snapshot, and that flow rate within an organ will depend on the path taken by the particular 'element' of tracer, there will be a spectrum of transit times, which may be described by its mean or modal value.
If t is the mean transit time then, fiom the central volume principle, F = V / r (1) where V is the volume of distribution of the tracer in millilitres.
The relationship between the amount of tracer in the organ's tissue and that in the blood will depend not only on flow, but also on the relative solubility of the tracer. The tissueblood solubility, or partition, coefficient, A, is defined as the ratio of the concentration of tracer in tissue (activity per unit mass) to that in blood (activity per unit volume), at equilibrium. If the concentration of tracer in tissue is assumed equal to that in blood, then the volume of distribution of the tracer is related to its mass, W , by
Thus equation (1) can be written as f = F / W = A / t (3) where f is the flow in units of millilitres per gram per minute or, conventionally, millilitres per 100 grams per minute. This is known as the tissue perfusion or compartmental specific flow, the flow for each compartment of tissue studied. Where estimation of tissue mass may be imprecise, for example where the field of view of the measuring device contains different tissues, then flow in units of millilitres per decilitre per minute is sometimes used.
The particular way in which flow is expressed depends upon the measurement technique:
reference will also be made to flow as a percentage of cardiac output and fractional flow, the fraction of the total blood flow, both of which are dimensionless, For some clinical purposes it is not necessary to go to the experimental complexities needed to measure flow in absolute units and, instead, the ratio of flow in an area of diseased tissue to that in normal tissue in the same organ and patient is used. A compilation of the normal resting flow values for a variety of organs has been published by Williams and Leggett (1989) . adapted to include a correction for background activity (Ferrant and Cauwe 1979) and a factor to compensate for the effect of source size on the amount of scatter (van Rensberg et a1 1988). This was reported as giving more accurate results than the simple geometric-mean approach.
When the source is close to the mid-line of the patient, or the source is thick, then the arithmetic mean gives a result similar to that of the geometric mean (Hiiada et 01 1967) . Graham and Neil (1974) combined this approach with corrections derived from transmission scans taken using plane sources of an appropriate radionuclide, but still found errors in excess of 10% at 140 keV.
A number of workers have used phantoms of the organ to be studied to provide a calibration of the camera data. Fleming (1979) used thin perspex phantoms of the same mea as a liver to obtain measurements of camera counting efficiency and the relevant linear attenuation coefficient Even so, he found errors of 5-10% in measuring the uptake of sulphur colloid in the liver.
The concept of a build-up factor was introduced by Siegel and Wu (Siegel and Wu 1982, Wu and Siegel 1983) to overcome the limitations of using the single-exponential approach to describe the contribution of scatter to attenuation. The technique has been applied to the measurement of ventricular volumes (Siegel et nl 1984) where an error of less than 4% was reported. Siegel also introduced the idea of a depth-independent build-up factor (Siegel 1985 , Siegel et a1 1985 . In a comparison of various techniques for measuring the uptake of * T P macroaggregated human serum albumin in the lung, an accuracy of 2% was claimed for the depthdependent factor and 3.5% for the depth-independent approach (Forge et a1 1991). The problem of scatter can also be approached by using correction circuits in the camera itself (Gagnon et aI 1989, Hamill and DeVito 1989 , H a l m et a1 1988) or by wing to estimate the proportion of scatter in the photopeak window either by measuring the relative number of counts in lower energy windows (Yanch et a1 1990, Jaszczak et a1 1984) or by using dual windows on the photopeak (King et a1 1992). Now that SPECT systems are available in many nuclear-medicine departments, planar imaging only offers a substantial advantage in the area of dynamic imaging, where only very specialized systems are able to produce tomographic images at reasonably high data rates.
Single-photon-emission computed tomography (SPECT).
Clearly, the main advantage of tomography is that it allows activity in the organ to be measured without contribution from neighbouring tissues. This is essential if meaningful flow measurements are to be made in organs consisting of tissues with different flow characteristics.
Since S E T uses the same gamma-camera detector as for planar imaging it is not surprising that several of the problems found in making quantitative SPECT measurements are those encountered in planar imaging. The principal one is to correct for attenuation, but, in addition, the effect of the reconstruction algorithm must be considered. A variety of algorithms are available but, recently, concern has been expressed that the same reconstruction algorithm produced hy different manufacturers may give different results (Janitt 1993).
As with planar imaging, a number of techniques have been suggested for reducing the effect of scatter: these include the use of dual energy windows (Jaszczak et a1 1985, Ogawa et ul 1991), and deconvolution using a point-spread function representing the contribution of scattered radiation (Msaki et a1 1988) .
The value of tomographic systems for demonstrating perfusion is limited by the inability to perform fast dynamic studies. Dedicated systems have been used (see technique (iii) in subsection 4.1.1.3) but the introduction of multi-headed SPECX systems into many centres may lead to dynamic tomographic flow studies becoming a routine procedure.
Positron-emission tomography (PET).
While this technique is considerably more expensive than SPECT, the coincident detection used in PET permits quantitation to be carried out to a much greater degree of accuracy. The attenuation of radiation depends only upon the total path length traversed by the two photons, not on the depth of the point of origin of the radioactivity. This distance, and the attenuation of structures within it, can be determined by a separate transmission scan, and an attenuation correction applied. In addition, spatial resolution is much better than in SPECT, about 3 m m compared with 9 mm, and varies very little throughout the slice. Thus while the partial-volume effect is still problematical, it is less severe than in SPECT.
The state-of-art PET imager is a multidetector and multislice machine, with the capability of performing rapid dynamic tomographic studies. This provides a very powerful approach to measuring organ blood flow (see subsection 4.1.5).
So far as blood-flow measurement is concerned, the main limitation with PET, and it is one shared by all the other techniques, is in defining the relationship between tracer kinetics and blood flow. Not only is this a question of understanding the biological behaviour of the particular tracer but also of defining how the tracer is presented to the organ of interest
Theory of blood-flow measurement
lntroduction
A wide variety of radiophannaceuticals can, potentially, be used as tracers of organ blood flow; their actual value depends upon the extent to which their behaviour can be related unambiguously to organ blood flow. There are two general approaches to using tracers for measuring blood flow. The first uses measurements of the dynamics of the tracer, its rate of passage through an organ, its clearance or uptake in the organ. By reference to a model of the flow of the tracer through the organ, flow can be computed from uptake (clearance) rate. In the second approach the static distribution of the tracer is assumed to reflect blood flow, this distribution resulting either from the equilibrium distribution of the tracer, where uptake and disappearance of activity are balanced, or the trapping of a bolus injection of the tracer on its first pass through the organ.
Dynamic techniques
The value of tracers for this type of study depends to a large degree on the rapidity with which they diffuse into tissue. This extraction occurs mainly at the capillaries since these have a large vascular surface area. This extraction process is often described by the RenkinCrone model menkin 1959, Crone 1964). The unidirectional extraction fraction, E , i.e. assuming that there is no back transfer of tracer from tissue to blood, is then given by where P is the capillary permeability for the tracer, S the capillary surface area, and F the flow. The model lacks realism in that it assumes that the capillary is rigid and that the permeability-surface-area product ( P S ) is independent of flow. A discussion of various models for the extraction process is given by Phelps et a1 (1981) . The extraction fraction of a variety of tracers has k e n measured for example, H2I5O by Eichling ef a1 (1974) and "NH3 by Phelps eta! (1981) . Despite the limitations of the model, it clearly demonstrates the problem that, unless a freely diffusible tracer is used, i.e. one whose extraction efficiency is 100%, then an additional flow-dependent term will be inwoduced into any model of the tracer kinetics.
If a tracer is completely non-diffusible, i.e. it remains confined to the vascular system with no exeaction into the tissue of the organ through which the tracer is flowing, measurements of flow can still be made. In thii case the volume with which the tracer is associated is the plasma volume within the tissue and this cannot be assumed to remain constant (Lassen 1977) .
Many of the dynamic techniques used for measuring blood flow are based on the Fick principle. This can be summarized as 'the quantity of metabolically inert substance taken up by tissue per unit time is equal to the quantity brought to the tissue by arterial blood minus the quantity taken away by venous blood'. In other words, it is a statement of the conservation of mass. For practical fncers, this statement is valid only when equilibrium has been reached, i.e. the concentration of tracer in arterial and venous blood is in a steady
State.
This principle can be used to measure blood flow by expressing it mathematicdy as where dQ/dt is the rate of change of the amount of tracer remaining in the tissue under consideration (megabecquerels per minute), C, and C, are the efferent and afferent concentrations (megabecquerels per millilitre) of the radiotracer, respectively, and F is the total blood flow rate (millilitres per minute).
3.2.1.
Single-compartment model. ?he simplest form in which the Fick principle has been applied to blood-flow measurement is based on the technique originally used by Kety and Schmidt (1945, 1948) who initially employed nitrous oxide as the tracer. It is assumed that the passage of the tracer through the organ can be modelled as a single compartment. If C(t) is the concentration of tracer in the organ (megabecquerels per gram), and using the partition coefficient, A, to express blood concentration in terms of tissue rather than venous concentration, then dC(t)/dt F/hW(AC,(t) -Cy)).
If it can be assumed that the arterial concentration, C , , is zero at the measurement time, then the clearance of the tracer from the organ can be described by
so if the slope, k, of the plot of log C(f) against f is measured, perfusion is given by f = 100hk.
(8)
This is referred to as the initial-slope technique and was first used to study cerebral perfusion by Ingvar and Lassen (1961) using "Kr and Glass and Harper (1963) with 133Xe. In both cases the material was injected into the internal carotid artery. Recirculation is minimal as the majority of the tracer reaching the lungs is exhaled while the remainder is distributed over the whole body. This approach has been widely used.
In circumstances where the arterial activity cannot be assumed to be zero but instead can be represented as a step input function, i.e., it rises sharply to a constant value, C ! , then the uptake of tracer as it reaches the saturation value will be given by 
where ki is the slope corresponding to the ith compartment.
Stochastic technique.
The compartmental models assume that each compartment is made of homogeneous tissue and that the blood and tissue concentrations are in equilibrium at all times. Deviation of the shape of the washout curve from the exponential form expected from this singlecompartment model can be accommodated by postulating multiple compartments. However, this does not necessarily demonstrate that multiple physiological compartments exist in the system; they may simply be a mathematical convenience. An alternative approach is the stochastic or non-compartmental method lint proposed hy Zierler (1965) . The washout curve is considered to be the result of individual 'particles' of tracer taking a range of times to cross from inflow to outflow of the organ and thus the curve can be interpreted as the frequency function of these uansit times. There is then no need to be concerned with the mechanisms by which the tracer is dispersed in the system; instead the organ can he considered simply as a 'black box' for which an average flow and an average volume of distribution of the tracer can be defined.
From this approach where Q(t) is the measured activity in the organ. Thus the specific flow (perfusion) can be calculated from the ratio of the height to the area under the clearance curve. This analysis avoids the need to assume that organ tissue is homogeneous or that blood and tissue concentrations are at all times in equilibrium. It does, however, involve a number of assumptions. Firstly, it supposes that all of the injected activity can be measured, i.e. that it is possible to integrate under the washout curve to infinity, and that during this long measurement time there is no recirculation of the tracer. It also assumes that the whole bolus of activity arrives in tbe field of view of the camera at the same time and so is represented
If the tracer used is diffusible, then A is the partition coefficient between the arterial and vascular components and so W represents the amount of tissue within the field of view of the detector. If, however, the tracer is nondiffusible then the volume refers only to the vascular volume and, as previously mentioned, the local plasma volume in tissue cannot be assumed to remain constant. Also the partition coefficient in this case refers to the ratio of fractional plasma volume in the organ to that in the blood (I-haematocrit) and this is difficult to measure accurately. The above analysis applies to the situation in which the activity is injected directly into the organ as an impulse. If this is not feasible then equation (13) becomes by Q(Q.
where A is the total injected activity. The problem then becomes one of ensuring that A and the integral under the curve are correctly normalized as they will now be measured by different detectors. If absolute flow is required then it is necessary to combine extemal measurements of the organ activity with that of the tracer concentration in the blood at the exit from the organ. If this is not practicable then allowance must be made for the deformation of the measured output function by the interposed collecting system. If the input function is not known, i.e. most commonly it is not an impulse function, then its shape must be measured.
When it is not feasible to record the complete washout curve, but instead measurement is finished after a time T , then equation (13) is most accurately approximated by (Bassingthwaite et al 1968) where Qp is the peak activity recorded.
Static techniques
3.3.1. Radiolabelled pnrticles. Saperstein (1958) observed that, with some radiotracers, the activity in an organ reached a plateau, which was then maintained for several seconds, and postulated that, in this case, the uptake is proportional to organ blood flow. The use of radiolabelled particles or microspheres, which are trapped in the narrow capillary vasculature, has replaced such tracers. The technique depends upon the following assumptions (Holman et al 1975): (i) the particles freely mix in the blood:
(ii) they lodge in the capillaries or at the capillary-arteriolar junction; and (iii) the resultant capillary blockage does not disturb the microcirculation of the vascular bed under study.
If Q , is the amount of radioactivity administered and Q is that residing in the organ, then blood flow to the organ is given by where CO is the activity in the organ.
The principal problem is the need to introduce the particles at a point in the arterial circulation. Clearly, injecting into the left atrium is not feasible except in patients already undergoing cardiac catheterization, and the alternative is administration directly into the artery feeding the organ. With the exception of measurement of Row to the lung, where venous administration can be used, this severely limits the technique. The technique also assumes that the organ's blood supply is solely arterial, an assumption not valid for the liver.
The problem of using this tracer for regional-blood-flow measurements is somewhat different. Recirculation has a lower effect on measurement as, firstly, the amount of recirculating tracer will be low, having been diluted in the whole body and, secondly, the distribution of recirculated tracer is similar to that on the first pass. The main problem is, however, that the distribution depends not only on flow but also on microsphere size and microvasculature geometry (Yipintsoi et a [ , Utley et al 1974 . It is suggested that, ideally, the microspheres should be 7-15 p m in diameter (Selwyn et a1 1986 ).
An interesting variation on this was suggested by Peters and colleagues (Peters et nl 1987) who proposed a technique in which the data from almost any gamma-ray-emitting tracer could be analysed as if it behaved like microspheres.
Chemical micmspheres.
While radiolabelled microspheres are available, their use is restricted by the route of administration. Other tracers that behave as microspheres but whose trapping in tissue depends upon some form of chemical process rather than the physical lodging in the microvasculature., have been referred to as chemical microspheres. A number of these tracers have been developed, in particular ' "I IMP and 99Tcm HM-PAO (subsection 4.1.4) and I3NH3 (subsection 4.1.5). However, they can suffer from a number of shortcomings, in particular Fi = SaCoICa (17) (i) extraction efficiency less than 100%, (ii) recirculation of the tracer, (iii) extracted material diffusing back from the organ into the blood stream, and (iv) trapping mechanism affected by the pathology of tissue.
Clinical applications
Cerebrul bloodj'bw
The brain has been the main focus for measurement of blood flow with radioactive tracer. This interest is undoubtedly due to the fact that in normal cerebral tissue changes in cerebral activity are accompanied by alteration of the cerebral metabolic state, which, in turn, results in a change in cerebral blood flow (Roy and Shemngton 1890 (ii) InIdation. Administering the gas by inhalation avoids the need to puncture the carotid Wery and allows the perfusion of both hemispheres to be measured simultaneously. This approach was first proposed by Conn (1955) who used radioactive xenon to measwe cerebral blood flow in dogs. He reported; in an abstract, that values in normal dogs compared well with the Kety-Schmidt technique.
Lassen and Munck (1955) described a method using the @ emitter "Kr based on the sampling of arterial and cerebral venous blood. Since it required 10 min to reach the steady state necessary if cerebral gas uptake is to be estimated from cerebral venous blood concentration, the technique was not suitable for the study of transient changes, This problem was overcome by Lewis et al (1960) who used the y-emitting 79Kr to make measurement through the intact skull using a scintillation counter. They found in a direct comparison with the nitrous oxide method that krypton gave significantly higher cerebral blood flow, an average of 83 d l 0 0 g min-' compared to 57.
The ventilation technique was first used in humans by Mallett and Veall(1963) , with the y-ray emitting 133Xe as the m e r . During the 20 min of gas washout they associated two compartments with the curve, one corresponding to grey and the other to white matter. From this they calculated an average perfusion rate of 52 mVlOO g min-' for grey matter and 10 mVlO0 g min-' for white. This gives an average value of 35 mV100 min-', substantially lower than that from the Kety-Schmidt technique.
There were, however, problems with using inhalation rather than intracarotid injection, namely significant arterial recirculation and the presence of extracerebral activity, giving a background component to the clearance curves. Using a correction based on activity concentration in the arterial blood or expired air (Veal1 and Mallett 1965, 1966) , the standard error for duplicate clearance measurements was found to be less than 5% and there was no significant difference between left and right hemisphere flow.
A comparison between the intra-arterial and inhalation techniques (Jensen er d 1966) showed that the underestimation was due to a slower component arising from non-cerebral sources. In fact, the extracerebral contamination constituted the largest source of error: only about 50% of the counts recorded actually came from the brain (Oldendorf 1969) .
Obrist et a1 (1967) applied a three-compartment analysis, together with a correction for recirculation, and produced blood-flow values close to those from the intracarotid technique. However, this required measurement of the clearance curves for over 40 min and, even then, it was difficult to discriminate between the second and third components. They also demonstrated that end-expiratory air could be used as a substitute for measuring activity in arterial blood. To overcome the problem of lengthy measurement of clearance times, Obrist et nl (1970) mixed together the two slowest components and used a two-component analysis.
This only required 1 min of gas inhalation, sufficiently long to saturate the fast cerebral component but giving minimal activity to the scalp and skull, and 12 min measurement for the clearance curve. Rao et ai (1974) showed that this technique could be used successfully with stroke patients, demonshating significant flow reductions in patients with more severe clinical disability.
The clearance technique was shortened further with a monocompartmental initial-slope model (Wyper et ai 1976) involving the inhalation of gas for 2 min and the monitoring of clearance curves for 2.5 min. This technique is simply the initial-slope technique used for the intracarotid studies and reflects the faster components of the clearance curve. The effect of extracerebral circulation is small, causing a 14% drop in normal CBF values.
The value of this approach depends upon the relevant information being present in the fast phase and the lack of contamination of this phase with other components. The 2 min clearance technique provides an index of mean blood flow, while the longer analysis of Obrist enables the faster grey-matter flow to be measured. Lassen (1977) states that it precludes the recording of smaller fast blood-flow components often seen in trauma and tumours, while also being insensitive to the low flow associated with ischaemia.
In addition to the problems identified above, only 16% of inhaled xenon will dissolve in blood and, of that, only 20% will reach the brain (Stokely et a1 1980) . Thus measurements must be made with high-sensitivity detectors with consequent poor spatial resolution. There will also be artefacts created by scattered radiation originating from xenon in the nasal air passages. Finally, there is cross-talk from activity in the opposite hemisphere (Risberg et a1 1975, Wyper and Cooke 1977) .
(iii) Tomogrnphic imoging. The value of tomographic imaging for removing the masking effect of flow in superimposed tissue has been mentioned earlier. '33Xe is a far-from-ideal tracer for tomography, its low energy leading to significant absorption and attenuation. If rCBF tomography is to be performed then rapid imaging must be performed to monitor changes in tracer concentration. Two systems have, however, been constructed: the 'Tomomatic', developed by Lassen et d (1978 ( , Stokely er a1 1980 and the 'Headtome', by Kanno et al (1981) .
The Tomomatic system consists of four blocks of 16 scintillation detectors rotating around the head every 10 s. In a typical study four images are taken of a particular slice over a period of 4.5 min and a clearance curve created (Lassen 1985) . The shape of the arterial input curve to the brain is deduced from a stationary detector placed over the right lung. CBF is calculated using the algorithm developed by Kanno and Lassen (1979) and by Celsis et n E (1981) based on the singleexponential clearance model. Since the data computed from such a clearance analysis will underestimate flow in low-flow regions due to activity spilling over from adjacent higher-flow regions, the image is scaled and linearized by the data from an image taken as the xenon enters the brain: this essentially gives an image similar to the microsphere technique.
Headtome consists of a circular arrangement of scintillation crystals with a collimator that moves so that data is collected f" different columns of brain tissue. An acquisition time of about 10 s is needed.
The major source of error is produced by Compton scattered radiation, it being estimated from phantom studies that almost half of the counts recorded over white matter are photons scattered from the high-count-rate grey matter (Shirahata et ul 1985) . In addition the l i i t e d spatial resolution will mix together signals from the white and grey matter, and there will be errors in the value used to measure the time delay between the appearance of activity in the lung and its arrival in the brain. The former gives an underestimation of about 15% and the latter an overestimation of 8%. Thus to some extent the errors may be expected to balance out.
In a group of 39 hedthy volunteers the flow in the left cerebra2 hemisphere averaged 56 i z 8 mVlOO g m i d , the same as that in the right hemisphere (56 3z 7) (Shirahata et al 1985) .
4.1.2.
Non-diffusible tracers. One of the earliest attempts to study cerebral blood flow was that by Nylin and Blomer (1955) who labelled the patient's own blood with thorium B before reinjecting it into the internal carotid arteT. The fate of the injected activity was studied by taking blood samples from the two jugular bulbs, and plotting the dilution curves. In a study on a series of 34 healthy males they found a mean circulation time of 8.5 s (range 7-10 s) but no correlation with blood pressure (Nylin et a1 1961).
Fazio et ai (1963) reported the use of 13'1 labelled albumin to study flow. They remarked upon the potential value of the monoexponential phase of the clearance curve as a measure of flow. The same group (Fieschi et a1 1963) also studied the effect of carbon dioxide on cerebral blood flow, again assuming that flow was reflected in the slope of the monoexponential clearance curve. The authors were very aware of the restrictions of the technique and did not claim to be able to measure specific flow in absolute units. In particular they noted the l i t a t i o n of assuming that the cerebral vessels represented a true mixing volume, that there would be different flow rates in various parts of the brain, the effect of the extracerebral circulation, scattered radiation and the depth-dependent sensitivity of the probe detector. Despite the limitations, this rapid measurement technique, requiring onIy a few seconds of measurement time, clearly demonstrated the haemodynamic response to a 5% mixture of carbon dioxide. Bell (1962 Bell ( , 1964 used an intra-arterial injection of 203Hg neohydrin or 13'1 HSA with probe detectors positioned over the internal carotid artery and at the confluence of the venous sinuses to measure transit times. He found the average arterio-venous transit time to be 6-8 s increasing to 10-13 s in cerebral aneriosclerosis.
Ojemann et al (1971) used an intracarotid injection of 99Tcm pertechnetate, with a specially designed multiprobe detector system with tapered collimators, to give near-uniform sensitivity over a volume equal to a cerebral hemisphere. This allowed them to make regional measurements of flow.
Various problems were recognized: the results with a non-diffusible tracer were particularly sensitive to the dispersion of the tracer before its entry into the brain, so much so that the Zierler height-over-area technique was not usable. Also, there was the problem, encountered earlier by Fieschi et a1 (1963) , that without concomitant measurement of regional blood volume, changes in transit time, such as produced by pharmacological or physiological stimuli, could be underestimated. However, while a non-dfisible tracer allows an independent measurement of regional blood volume to be made (Glass eta[ 1968) , the necessary criteria, namely that the rate of clearance from the blood pool should be small compared with the rate at which equilibrium concentration is reached, is not met with 99Tcm pertechnetate. Ojemann and colleagues therefore defined a number of circulationtime measurements not unduly affected by the extracranial circulation. However, the same group also proposed a stochastic model that would allow mean TCBF and CBV to be measured (Hoop et a1 1971). Since it is clear that these techniques depend upon a sharp bolus input, which can only be achieved by an intracarotid injection, the technique had limited general applicability.
Intravenous injection is clearly preferable to the more invasive intra-arterial method. However, for this approach to give clinically useful results, corrections must be made for the significant additional transit time between injection and arrival in the cerebral area and for recirculation. Oldendorf(1962) measured the uptake and clearance curve using specially collimated detectors designed to take measurements from both hemispheres simultaneously. Particular care was taken in devising a technique for producing a sharp bolus injection. 1311 iodohippurate was used as the tracer as it had the particular advantage for a tracer of being rapidly excreted by the kidneys, so minimizing recirculation. The transit time was defined as the time between the point of maximum rise and fall of the curve simply because these were readily identifiable landmarks on the curve. In 15 normal subjects circulation times of between 6.5 and 10 s were recorded.
In further work Oldendorfand Kitano (1965 Kitano ( , 1967 demonstrated that there was, in fact, a range of transit times, with a mode of about 6 s and a mean of 7 s in healthy young adults, reflecting the variable path length taken by a tracer. Although prolonged in cerebrovascular disease, it was unlikely that the existence of a focal abnormality would, of itself, increase the transit time.
The intravenous approach is particularly attractive if it allows measurements to be combined with conventional brain imaging, such as when 99Tcm pertechnetate is the tracer. Linder et a1 (1980) , using an intravenous injection of 99Tcm pertechnetate, measured the inflow of activity to the brain and applied a modified version of the height-over-area technique to calculate flow. This allowed them to measure flow over a period of 80 s considerably shorter than the diffusible gas washout approach, and, by using a gamma camera, regional-flow measurements could be made. To correct for the dispersion of the injection, they applied a correction factor whose value was empirically determined and depended on the quality of the injection. Recirculation of the tracer was corrected by a logarithmic function subtracted from the time-activity curves (TACS). The technique appeared to be very sensitive to the curve smoothing employed to allow corrections to be made. Absolute values of flow were then calculated assuming a constant value for the blood-brain partition coefficient. They did not evaluate the technique on normal subjects, but, on patients showing no abnormal pathology on the static images, they found flow values comparable to those obtained using the xenon-clearance technique.
In studies on rats, Keyeux and Ochrymowicz-Bemelmans (1983) demonstrated that the behaviour of 99Tcm pertechnetate was neither that of a diffusible nor a non-diffusible tracer. However, they concluded that its distribution in the head could be described by a twocompartment model, with the fast component giving information similar to that from xenon clearance.
Both xenon and %Tcm pertechnetate were used by Kuikka et a1 (1977) to measure blood flow and volume in the same patients. Grey-and whibmatter flow were measured using the two-compartment model with intravenously administered xenon, the input arterial curve being reconstructed from measured expired activity. The mean transit time (MTT) was determined from the 99Tc"' dilution curve measured over the hemispheres and cerebral volume determined from equation (1). The MTT was 3.9 f 0.7 s for 40 year olds and the mean flow 52 & 7 mVl00 g min-'. They reported no difference between this measure of flow and that obtained using intra-arterial injection or inhalation of xenon, provided that recirculation was taken into account.
Britton and colleagues (1980, 1985) measured the TAC of intravenously injected ggTcmlabelled HSA obtained with a gamma camera positioned to give a vertex view of the brain. This was deconvolved using the TAC from a probe detector viewing the aortic root, to give the retention function of the tracer in cerebral tissue. The M?-T is then calculated from the area under this function divided by its peak height (see equations (1) and (13)). These data, together with a timed measurement of blood activity, are also used to calculate the cerebral volume. From this and the MTT the blood flow in millilitres per minute can be calculated. The technique has been applied to a study of cerebrovascular disease pritton er a E 1979).
This technique has the advantages over others of measuring both volume and transit time and of making no assumptions about compartmental models or about partition coefficients.
Deconvolution is, however, very sensitive to noise and while flow values could be measured for regions within the vertex view, it was necessary to use large regions of interest (ROB). Carlsen and Hedegaard (1987) used 99Tcm pertechnetate and positioned the gamma camera so that TACS could be recorded from over the two cerebral hemispheres and the aortic arch in a single view. They dealt with the problem of recirculation by fitting a gamma variate function to the TACs. By also applying this to the aortic-arch curve the shape of the input function could be found. The gamma function fitted to the cerebral TAC represented the convolution of the dispersed input, the aorta curve, and the true impulse response of the cerebrum. Assuming that the cerebral hemispheres could be represented by a single-compartment model, they calculated the cerebral MTr corrected for both the transit time to the cerebrum and recirculation. For normal subjects aged between 20 and 60 years the MTT was 3.2 zk 0.67 s but there was no variation with age.
There are a number of criticisms of this technique. Firstly, the single-compartment model will not be valid in certain conditions, e.g. in stroke. Secondly, as has already been mentioned, 99Tcm is not an ideal non-diffusible tracer. Finally, there are questions as to the validity of the gamma fit, particularly the assumption made that there is a time interval of 2 s between injection and appearance in the cerebral ROI and 1.5 s between aortic arch and Menick et al (1991) used a gamma-camera vertex view and a separate probe detector over the aorta. As with Carlsen and Hedegaard (1987), gamma-variate fitting was used to calculate the transit time but in this case the MTT from injection to aortic arch was measured from the aorta TAC, and the M T r from injection to exit from the cerebral field of view, from the vertex TAC. By subtracting the two transit times the cerebral m s i t time could be calculated. They found that the transit time followed the form MTT= 4.4 + 0.0037 age (years), giving an MTT of 4.54 s for a 40 year old.
They also recognised the confounding problem of blood volume and proposed using an image showing the interval between arrival at the aortic arch and in the head. They advised that late tracer anival and prolonged transit times associated with the same pixel should be interpreted with caution.
cerebrum.
In a second paper by the same group (Naylor et a1 1991), they demonstrated a linear relationship between hemispheric M" and end-tidal carbon dioxide. (1986) used PET to study distribution of "Clabelled human-albumin microspheres in the brain following administration into the left venhicle after cardiac catheterization. In 10 patients, aged from 42 to 68 years, all with a previous history of myocardial infarction, the mean cerebral blood flow was 52.4f 10 mVlOO g min-' in the frontal lobes, 55.4H.8 in the temporal lobes and 67.7f8.2 in the occipital region. Crean eta1 (1986) used "Tcm human-serum-albumin microspheres, also injected into the left ventricle of patients undergoing cardiac catheterization. Having measured the cardiac output, the standard Saperstein formula (equation (13) The first such tracer to be developed was N-isopropyl-iodine-123-iodoamphetamine (IMP) (Winchell et ai 1980% b) . Studies in humans (KIN et al 1982) showed that the tracer distribution remained relatively stable for about 1 h after intravenous injection, slow washout of tracer from the brain being replaced by new IMP from the pulmonary reservoir.
Radiolabelled partkles. Selwyn et a1
However, it was noted that the distribution of hlp changed after the first hour.
In the same paper, Kuhl et nl compared i 2 3 1 -~ uptake in dogs with that of microspheres and found good agreement over a wide range of flow rates. Assuming that the initial distribution of IMP was similar to that of microspheres, Kuhl et a1 used equation (17) Quantitative measurement of flow has also been made by Greenberg et al (1990) and by Takeshita et a1 (1992) . Greenberg employed a two-compartment model assuming hlp to be freely diffusible from blood to brain and having a constant rate of back diffusion (Matsuda et a1 1986) . The unmetabolized IMP was determined by octanol extmction from arterial blood samples. In normal subjects flow was found to be 47.3 ml/lOO g m i d , about 20% less than that measured with PET in the same patients. This difference was attributed to the extraction fraction being less than 100%.
Takeshita et a1 also used dynamic SPECT to measure the rate of uptake of IMP by the brain. It was also necessary to use octanol extraction to measure the rate at which IMP changed from a lipophilic to a hydrophilic form in vivo, but this could be done using only a single blood sample rather than the continuous blood extraction required by the other techniques. In young healthy volunteers flow values of 71.7 ml/lOO g min-' were found in the cortex and 54.8 for the cerebral hemispheres.
While the dynamics of IMP do not make it suitable for quantitative measurement of rCBF on a regular basis, it found wide clinical applicability for a time. However, it suffered from a number of shortcomings: in particular, the redistribution of the material indicates that it is not a pure flow tracer.
A second iodinated tracer, iodine-123-hydroxyiodoproplyldiamine (HIPDM), was developed to overcome some of these problems (Kung et a1 1983) . It is trapped in cerebral tissue by the pH-shift mechanism. In the intravascular pH range the material is lipophilic and enters the brain but once in this acidic compartment it becomes positively charged and is unable to diffuse out (Luciagni et af 1985, Kung et at 1983) . Clearly it is unsuitable for conditions that lead to tissue acidosis, and its singlepass extraction is lower than that of IMP, only 78-90% in normal tissue (Luciagni et nl 1985) .
Another alternative was thallium-201 diethyldithiocarbamate @e Bruine ef a1 1985, van Royen ef a1 1987). Unfortunately the imaging characteristics of *' ' TI are poor and this agent never achieved the same level of clinical acceptance as IMP.
The most successful of the cerebral-blood-flow agents to date has, undoubtedly, been 99Tcm hexamethyl propyleneamine oxime (HM-PAO). Volkert and colleagues (Volkert et a1 1984) first proposed that propyleneamine oxime complexed with 99Tcm might prove useful for measuring rCBF. Its washout, however, proved to be too rapid. Results on a derivative of this material, hexamethyl propyleneamine oxime, showed much better retention in the brain (Holmes et a1 1985) . A study of two diastereoisomers isolated from the HM-PAO, the meso and d, 1 forms, revealed that it was the d, 1 isomer that showed the selective concentration in the brain (Sharp et a1 1986b) . Its uptake in the brain, 4%, was comparable with that of IMP, and there was no indication of redistribution of the cerebral material over a period of several hours.
The mechanism for trapping is reported as being due to the conversion of lipophilic HM-PA0 to a hydrophilic form by a glutathione-dependent mechanism in brain tissue (Neirinckx et a1 1987) . However, the tracer does not behave like microspheres: the extraction efficiency into cerebral tissue is only about 75% (Anderson et a f 1988a) ; the tracer is not trapped instantly in the brain and a significant amount of back diffusion from brain to blood takes place (Sharp ef a1 1986b, Lassen et a f 1988) .
Thus, if quantitative information is to be obtained on blood flow, it is necessary to take account of both the back diffusion and the amount of hydrophilic tracer in the blood stream that is available for trapping, i.e. the input function to the cerebral tissue. An algorithm to wrrect for these deficiencies, based on a threecompartment model of the kinetics of HM-PAO, has been developed (Lassen eta1 1988).
Anderson reported a comparison between flow as measured with HM-PA0 and the xenon initial-slope measurement (Anderson et a1 1988b) . Patients with a variety of cerebral pathologies as well as controls were studied. The ratio of count rate over the abnormal area to that in a normal cerebral region for HM-PA0 versus the ratio of flow in the same regions as measured by 133Xe followed the line of identity until high flows were reached (ratios of 1.5), when the curve flattened as expected in the presence of back diffusion. The application of the Lassen correction restored it to linearity. When the cerebellum was used as the reference region the correlation was reported to be poorer, the difficulty probably being the measurement of cerebellar flow with 133Xe. Six HM-PA0 studies were also performed in which the Fick principle, utilizing arterial and venous blood samples, was used to measure average flow in absolute units. This showed a reasonable correlation with the xenon results.
Absolute flow has also been measured by assuming that HM-PA0 behaved as microspheres and using the constant-withdrawal approach of equation (17) (Pupi et al 1991) . They also compared the results with %Tcm microspheres in the same patients. The main problem was to define the input function since it was necessary to distinguish between activity associated with diffusible and non-diffusible tracer. The octanol-extraction technique was used but account was also taken of the proportion of non-diffusible tracer present in the octanol-extracted fraction. While conceding that these measurements had been made over a limited range of flow values, they showed a linear relationship between the two flow measurements. They concluded that this approach represented the best measurement of flow by SPECT. However, as pointed out in an accompanying editorial (Rattner eta1 1991) , the determination of the diffusible activity is time consuming, the technique requires some form of calibration, using a phantom, between count density measured from the SPECT image and absolute concentration of activity in the brain, and there is a wide spread in the reported results.
A dynamic S P E~ approach was used by Matsuda and colleagues (1988) to plot the temporal variation of activity in the brain and blood. Using the four-compartment model of Lassen and a parameter-estimation analysis of the blood and tissue TACs, the input function of diffusible tracer was calculated, so avoiding the need for octanol extraction. They also demonstrated that the blood-brain partition coefficient for the diffusible component was close to unity for grey matter.
The above techniques suggest that flow can be deduced from " 4 0 uptake, but not in a simple fashion. As the potential advantages of having some quantitative measure of flow are considerable, particularly in conditions where there might be a generalized rather than focal flow change, several authors have tried to obtain a semiquantitative measure based on the count-density pattern in the SPECT images normalized in some way. The evidence available suggests that this may not be possible. Both Yonekura et al (1988) and Gemmell era1 (1990) compared flow measured by NM-PAO with that determined with C " 9 . Yokenura et a1 showed that the Lassen linearization algorithm improved the linearity when relative flow measured by HM-PA0 was plotted against absolute flow determined by PET. The study by Gemmell et nl was on demented patients; plots of HM-PAO uptake, expressed as a percentage of that in the cerebellum, showed poor correlation with flow as measured with PET. However, when this HM-PA0 percentage value was multiplied by the corresponding PET cerebellar flow value, then the data showed good correlation with the PET cerebral values. This, they suggested, demonstrated that normalization of HM-PAO uptake using the (HM-PAO) cerebellum uptake was not valid, at least for patients suffering from dementia, and, indeed, raised the question as to whether any simple quantitation of flow could be done on HM-PA0 SPECT images.
Various clinical comparisons of the different agents have also been performed. HM-PA0 was reported to give similar images to HIPDM (Leonard er a1 1986) but demonstrated slower changes with time. However, while the HM-PA0 uptake pattern in normal volunteers was similar to that obtained with IMP, more lesions were seen with IMP in demented patients (Gemmell et ui 1988) . The investigators expressed the opinion that the greater convenience of HM-PAO would outweigh this slight shortcoming.
The development of tracers continues, one of the most recent being T691 (Taylor et a1 1992), which, while having a different binding mechanism to HM-PAO, still suffered from the shortcomings of an extraction factor less than 100% and back d*ion.
Despite the problems in obtaining reliable quantitative measures of blood flow, these cerebral-flow tracers have had a significant impact upon routine clinical nuclear medicine. The potential role in the diagnosis of cerebrovascular disease was quickly recognised (Hill et a1 1982). discordance was reported between the information provided and that from x-ray a (Lee et al 1982) and it has been suggested that this might play a role in assessing prognosis (Mowitz et a1 1990) . The tracers have been widely used in the differential diagnosis of dementia, particularly with regard to Alzheimer's dementia (Sharp et a1 1986a A good review of the applications of these agents is given by Holman and Devons (1992).
Positron tracers.
Tracers utilizing positron-emittiug radionuclides have been widely used to study cerebral blood flow, the general background being covered in a number of reviews, for example, those by Ter-Pogossian and Herscovitch (1985) and Lagreze and Levine (1987) .
While a number of tracers have been suggested, the principal one for measuring cerebral blood flow is HzlSO. This has several advantages as a flow tracer: flow; or pharmacologic side effects; (i) it is biologically inert, so its distribution does not depend on factors other than blood (ii) it is a naturally occurring component of the body with no undesirable physiologic (ii) its relatively short half life of 122 s facilitates repeat studies; (iv) its partition coefficient is less dependent on pathology than that of other tracers; and (v) it can be administered either as an intravenous injection or produced in vivo by inhalation of ~'~0~.
One shortcoming is that radiolabelled water is not 100% diffusible across the blood-brain barrier, as assumed by the use of the single-compartment model. Eichling et al (1974) suggest, on the basis of measurements on monkeys, that it is about 95% diffusible. Another shortcoming is that unlike gases there will be no clearance of water from the lungs and so there is a greater recirculation.
As with all diffusible tracers, measurements of flow have been made using data from either the equilibrium distribution of the tracer, the clearance dynamics, or the trapping.
In equilibrium imaging C"02 is administered by inhalation, the water in the blood being labelled by exchange between carbon dioxide and water under the catalytic influence of carbonic anhydrase in the red blood cells in the pulmonary vasculature (West and Dollery 1962) . In this way a constant arterial input of labelled water can be given to cerebral tissue. The labelled water is taken up by cerebral tissue and equilibrium levels of activity are observed in the brain after (1982) made a theoretical estimation that, with the PET imager technology of that time, the coefficient of variation of CBF should be about 10%. Finally, since it takes about 10 min to reach equilibrium, not only is the radiation dose high but repeat studies are impractical.
As radiolabelled water can also be administered intravenously the uptake technique of equation (11) A 40 s long PET image is acquired after the arrival of activity in the brain following a bolus injection; simultaneously arterial blood samples are taken. As PET imaging does not permit the instantaneous measurement of uptake at a specific point in time, equation (11) is modified to
(
19) TI
The technique, often referred to as the autoradiographic technique, was found to he insensitive to errors in A. but very sensitive to the difference between the time of arrival of activity in the brain and sampling site. In a study on baboons, flow values were compared with those measured from an intracarotid injection of water (Raichle et a1 1983) . Good correlation was found at low values of rCBF, but at high rates (equivalent to approximately 55 d / 1 0 0 g J I I X " in humans) flow was significantly underestimated, due to the permeability limitation of the brain for water. The authors also calculated that the difference between A values for grey and white matter was unlikely to give an error in flow greater than 4%.
The short half-lie of I5O is essential to the success of the technique as data acquisition cannot be carried on for longer than 60 s from the arrival of activity in the brain but, as a consequence, high activities must be used.
The thud technique utilizes measurements of the rate of clearance of the tracer from the brain. Since this technique has largely involved rapid dynamic studies, its development has been dependent on the availability of suitable PET instrumentation. This approach was first studied using inhalation of the diffusible tracer 77K.r (Yamamoto et a1 1977) utilizing a ring-detector positron scanner, which permitted images to be taken every 20-30 s for 6-10 min. 7 7~ has a half-life of 73 min so, unlike I5O, the conhibution to the clearance of activity by physical decay is not very significant. The normal average cerebral blood flow was 54.6 f 5.5 m1/100 g min-'.
Clearance measurements of H2 150, after either a bolus intravenous administration or indirectly by bolus inhalation of Ci502, were first described by Huang et al (1981, 1982, 1983) . The input function was computed from arterial blood samples taken over a period of 10 min post-injection. A sequence of five 2 min PET images was taken immediately following injection and clearance curves produced. The flow, f, and the distribution volume of water, V (where Q(t) = C,(t)V), can be found from
where k is the decay constant for I5O, the asterisk indicates that the activity is decay corrected, and the integrations arc over the whole measurement period, T.
The technique only requires measurements of tissue and blood activity at a series of times. There is no need to reconstruct all the image data, instead Q dt and J Q* dt images can be integrated d m t l y from the projection data; this approach is referred to as the 'integrated-projection' technique. Clearly it avoids any problems associated with the need to assume a value for the partition coefficient. However, the bolus injection may cause difficulties with detector dead-time and the total acquisition time of 10 min may also be unduly long for some types of study. Flow values of 59 f 11 and 20 3= 4 m1/100 g m i d
were found for grey and white matter, respectively, in seven normal volunteers.
In order to achieve greater accuracy this approach has developed along two lines. A more general form of equations (20) and (21) Yokoi etal demonstrated that ICBF was estimated with a greater accuracy than with either C i 5 0 2 steady-state or HZ 150 autoradiographic measures. The flow values were shown, in a simulation study, to underestimate the true value by about 5%. However, as with the integrated-projection technique, values were found to vary with scan duration, T . This, it was postulated, might be due to the limitation of the single-compartment model, tissue heterogeneity, and the effect of dispersion and time delay of the arterial input function.
Another development has been made by Lammertsma and colleagues, who also used multiple scans taken throughout the build-up and retention phases of a constant inhalation of CI5O2 (Lammertsma et al 1989 (Lammertsma et al , 1990 . They also define the dispersion of the arterial curve in terms of a single exponential but use the acquired image data to assess the shape and timing of the input function.
?fpicaIly, subjects inhale a constant supply of C l S 9 for 2 min while four image frames of 5 s and 16 of 10 s are acquired. Concurrently, arterial whole-blood time-activity curves are measured. A timeactivity curve from an ROI over the whole brain is then generated from the 21 reconstructed images and, from this, values for the dispersion parameters of the assumed exponential input function are calculated. From these values the true input function can be calculated by deconvolution of the input function measured from the radial artery. A look-up table of CBF as a function of the integrated image counts is then generated and, using this table, functional images of CBF are produced. The whole study takes 3.5 min and the blood-flow values are independent of study duration. Lammertsma et a1 also suggest that with only a small loss of accuracy, the need for rapid dynamic studies could be avoided and only a single 2 min image acquired.
The single-compartment model was also validated by Iida et al (1989) , who assumed values for exponential dispersion constant.
While freely diffusible tracers are widely used to measure flow, one PET tracer approximating to the microsphere model has been applied, namely 13NH3 (Hunter and However, as only about 50% is extracted in a single pass, uptake will be inversely related to Q3F in a non-linear fashion and so give a poor response to flow changes at high flow rates . 13NH3 has been applied clinically, although not quantitatively, in stroke (Kuhl et a1 1980b) and epilepsy (Kuhl et al 1980a) .
Cardiac bloodfiw
The value of cardiac-blood-flow measurements is that they may help to define the physiological significance of lesions seen at arteriography. As the studies require intraarterial injection they are performed at the same time as coronary arteriography. The Kety-Schmidt washout technique has been applied to this problem using "Kr (Klein et al 1965) and 133Xe (Ross et al 1964) . Ross found flow in the normal resting patient to be 50 d l 0 0 g min-' when the injection was made through the right coronary artery and 61 ml/lOO g min-' when made through the left; the difference was not statistically significant. As these early studies only looked at large volumes of tissue the effect of regional changes in flow was obscured.
Measurements of regional flow using the xenon-washout technique have been reported using both the gamma camera (Maseri er a1 1971 , 1972 , Dwyer et al 1973 . Cannon and colleagues (1976) used the single-exponential approach over the fist 40 s of washout as this curve was hear when plotted on semilogarithmic paper, the initial portion of the washout curve is least affected by nonmuscular tissue, and there was good correlation between this approach and directly measured flow.
The technique has certain problems. Cardiac motion makes measurements from small regions difficult, cross-talk from other myocardial surfaces is inevitable in a two-dimensional image, and the partition coefficient may vary in pathologically abnormal tissue where, for example, fatty infiltration is present.
In 12 patients with normal cardiac work-up, Cannon et nl (1975) reported an average mean Lv myocardial blood flow of 61 f 7 d / 1 0 0 g m i d ; it was only in the group with significant obstructions of both the LAD and right coronary arteries that a reduction was found, 43 i 14 ml/lOO g min-l (Cannon et al 1976) . Maseri and colleagues (1971) used a gamma camera to acquire data after introducing xenon dissolved in saline into the patient's right or left coronary artery, a single exponential curve being fitted to the first 100 s of washout. In three patients with normal coronary arteriogram they found an average flow of 56 ml/100 g min-' to the base, 77 to the centre and 73 to the apex.
Holman et al (1974) also used a gamma camera to monitor the clearance of xenon injected into the left coronary artery: it was found that over 30 min of clearance the curve was represented by three compartments. From an examination of the camera images they suggested that the slowest one was clearance from fat, while the other two corresponded to homogeneous distribution of tracer implying that both represented myocardial perfusion.
No significant difference in the blood flow associated with any of these three compartments was found between patients with normal and abnormal coronary arteriograms, in line with the results of Cannon et al. The flow associated with the fast compartment was 77 f 23 ml/lOO g min-'. However when functional images were generated showing the regional dishibution of flow values computed from the initial fast compartment, then patients with single or multiple-vessel disease had considerable greater heterogeneity than normals.
The retention of xenon in fat was noted as causing problems when repeat studies were required.
Using "Tcm human-serum-albumin microspheres, Crean et a1 (1986) measured myocardial blood flow as 266 f 82 ml min-' in patients with normal cardiac indices (see subsection 4.1). Applying the Saperstein principle with *O'TI thallous chloride as the tracer, an uptake of 3.2 zk 0.32% cardiac output to resting cardiac tissue was measured by Svensson and colleagues (1982) . Albumin microspheres labelled with the positronemitting "C injected into the left ventricle during cardiac catheterization have been used in one study in humans (Selwyn et ai 1986) . Blood flow to normal myocardium averaged 82 & 32 m1/100 g min-', while in the centre o f infarcted myocardium it was Radiolabelled water, as has already been mentioned, is particularly attractive, being a freely diffusible trace that is completely extractable and retained in the myocardium after its first pass through the coronary circulation. The extraction is almost completely independent of blood-flow rate and the uptake in myocardium is not significantly altered by changes in metabolism (Bergmann et al 1984) . It has one significant drawback, namely that the tracer labels the myocardium and blood pool simultaneously and therefore some form of correction for blood-pool activity must be applied.
Bergmann and colleagues (Bergmann eta1 1984, Walsh eta! 1990) describe a technique in which a correction for blood activity is achieved by using Cl5O to label to blood pool. Absolute flow is measured using the single-compartment-clearance model, the clearance curve being calculated from a series of short-exposure PET images. The the-activity curve from the blood pool in the left ventricle or atrium is used as the source of the input function. In 11 normal subjects, myocardial perfusion at rest was 90 ?c 22 m1/100 g m i d
and the coefficient of variation from multiple regions of interest across the myocardium was 35 zk 10% .
Iida et al (1988) also introduce a correction for the partial-volume effect, where the activity in the relatively thin-walled myocardium is blurred into that of the blood pool by the limited spatial resolution of the PET imager. Again this is based on the Kety clearance technique and Ci50 is used to correct for blood activity. However, in order to achieve the necessary accuracy to correct for the partial volume effect, arterial blood sampling must be used to obtain the input function. The mean value for absolute blood flow in normal subjects was 95 5 9 m1/100 g m i d . The positron-emitting &er 13NH3 has been used as a myocardial tracer. Its behaviour is intermediate between that of a freely diffusible tracer and microspheres. It is highly extracted by myocardium and retained in tissue in propoltion to blood flow (Schelbert et a1 1981) . The movement of ammonia between the vascular and extravascular space is determined by diffusion while its retention in the myocardium is by metabolic trapping by glutamine synthasase to 13N glutamine (Schelbert et al 1981 , Schelbert 1987 . The consequence is that retention represents a combination of blood flow and metabolism. Unlike HZ "0, the first-pass extraction of l3NH9 is less than 100% and declines with higher blood flow, so giving an underestimation of blood flow, although this does not appear to be caused by changes in metabolism (Schelbert et a1 1981) . in addition, substantial amounts of 13N-labelled metabolites, such as amino acids and urea, are found in the blood as early as 5 min post-injection (Rosenspire et a1 1990) and will contaminate the input function. To overcome these problems Hutchins et al (1990) suggested the use of dynamic PET imaging, in which "NH3 is given intravenously as a bolus over 30 s while fast imaging is carried out simultaneously; 12 10 s frames followed by 4 30 s frames and one 360 s frame. The time-activity curves were fitted with a tiueecompartment model of uptake, the first component representing the concentration of 13NH3 in aderial blood, the second the transport between vascular and extravascular space, and the third the trapping in myocardial tissue.
In seven healthy volunteers (mean age 24 f 4 years) they measured an average myocardial blood flow of 88 f 17 ml/100 g m i d . (Bianco 1990 , Schelbert eta1 1990 . In two recent studies, using a canine model, both ammonia and water were found to Correlate with flow as measured with microspheres. This correlation held for both high-and low-flow normal myocardium as well as in infarcted myocardium (Bo1 et 01 1993, Muzik er al 1993).
Renal bloodjlow
Renal blood flow is of special interest since it far exceeds the metabolic needs of the kidney and varies considerably withiin the kidney. In renal cortex it averages 400600 ml/l00 g min-' and in the outer medulla it is in the range 100 &lo0 g min-', while in the renal papilla it is at its lowest, 10-40 ml/100 g min-'. Flow has been studied using the initial-slope clearance technique following the intraaterial injection of a diffusible gas although a number of questions concerning this approach have been rasied (Hollenberg et al 1976) .
In dogs a four-compartment model best describes the clearance curve (Thorburn et a1 1963), the fastest component representing cortical perfusion, the others being perfusion rates in the outer and inner medulla with the slowest reflecting radioactivity in renal fat. In man the fastest component is absent when the cortex is totally necrotic (Hollenberg et  a1 1968) . Gamma-camera images of clearance show a decrease in kidney size consistent with disappearance from the cortex prior to that from the more central areas (Kinoshita  et a1 1974) . but the structure of the kidney makes further deductions difficult from twodimensional images. It appears that, given the limitations of compartmental analysis, the rapid-clearance component reflects that portion of the renal blood flow that is perfusing the renal cortex at a rate sufficient to sustain glomerular filtration.
Measurement of renal blood flow by the xenon method in normal subjects has been largely limited to potential kidney donors who require selective renal arteriography as part of their work-up mollenberg et al 1974). It is clear from chis work that there are two important biological factors affecting the results. The first one is age, with total renal blood flow beiig constant until about 40 years of age and then progressively declining by about 10% per decade. The second is the state of the subject's sodium balance, sodium loading increasing flow. Values of 455&29 ml/lOO g min-' for six normal males aged 23-27 years have been reported (Ladefoged and Pedersen 1967) , while the cortical flow had a mean value of 538.
The xenon washout technique has been used in a number of clinical situations. Blood flow was reduced in hypertension (Ladefoged and Pedersen 1969) ; in essential hypertension flow was found to be 197 + 13 ml/lOo g ruin-' while with renal artery stenosis there was a flow of 219 & 11 m1/100 g min-' to the stenotic kidney and 251 &9 to the contralateral kidney, thii difference being insignificant. There was no correlation between degree of stenosis and blood flow, which was in agreement with Hollenberg and Adams (1971) who found that the mean renal blood flow was reduced to 212 k 11 m1/100 g ruin-'; the flow rate of the rapid component was reduced but the percentage of total flow associated with the rapid component was unchanged.
In acute renal failue, a reduction in mean renal blood flow to one-third was associated with absence of the rapid component, suggesting a global reduction of cortical perfusion (Hollenberg eta1 1968, Kinoshita et af 1974, Hollenberg et a1 1970, Pedersen and Ladefoged 1973) . In contrast, in acute bilateral cortical necrosis mean blood flow is reduced to 10% of normal (Hollenberg et uf 1968), consistent with almost total cessation of flow to the cortex. Chronic renal failure results in flow falling more than GFR, the most obvious change being a reduction in the flow associated with the fast component. This is consistent with a reduction in the fraction of the renal cortex receiving a perfusion rate adequate for filtration. The value of diffusible tracers for measuring intrarenal perfusion has been questioned (Auckland 1975 ) but, nevertheless, it was suggested that they might give reasonably good estimates of average renal blood flow.
The Peters method (subsection 3.3.1) gave a value for the blood flow to both normal kidneys of 19.4& 1.5% carbon monoxide peters et af 1987) and, using labelled red blood cells, the mean renal transit time was found to be 15.2 f 3.7 s. This contrasts with a value of 4.7 s reported by Ladefoged and Pedersen (1967) . The technique has also been applied to paediatric renal transplants (Ash et a1 1990). Svensson etuf (1982) used the regional distribution as shown on gamma-camera images of intravenously injected *OITI thallous chloride. The technique is based on the Saperstein princple, mlTI being more suitable than potassium as a higher proportion of the activity entering the coronary and renal arteries is extracted by the heart and kidneys while organ hlm-over rate is slower (Straw and Pitt 1977). 12.5 f 1.91% of the injected dose was found in the kidneys of six males aged between 33 and 49 years.
Selwyn et a1 (1986) used "C-labelled microspheres and positron tomography to measure renal blood flow in 10 patients with known myocardial infarction. A mean value of 163 & 84 m1/100 g min-' was found for the right kidney and 166 f 81 for the left.
While many workers have produced indices of renal perfusion, rarely do they give quatitative measure of renal blood flow. Rutland (1981 Rutland ( , 1985 has proposed a technique that analyses the first few seconds of a conventional renogram, using 99Tcm DTPA, to give a renal-blood-flow index. This avoids the need to use deconvolution. A total renal blood flow of 1020 ml min-' was calculated for patients between 15 and 55 years.
Using 99Tcm 
Lung bloodflow
The use of an intravenous injection of 133Xe was first described by Ball et al (1962). An intravenous injection of 133Xe dissolved in saline is given while the patient holds their breath at some preselected volume until the equilibrium count-rate is reached. The ratio of the regional concentration of gas to that expected had the gas been uniformly distributed throughout the measured volume is known as 'the index of performance per unit lung (gas) volume'. The technique is described in more detail by Milic-Emili (1971).
The measurement of lung perfusion using an intravenous injection of the short-lived slW was first proposed by Jones (1970) although the first human studies were presented by Yano et a1 (1970) .
llC-labelled microspheres of human serum albumin introduced into the left ventricle during cardiac catheterization were used to measure lung blood flow in 10 patients with a diagnosis of myocardial infarction (Selwyn e t d 1986) . T i e d withdrawals of arterial blood permitted uptake measurements to be converted into flow values. The flow to the right lung was 1.4 f 0.5 ml/lOO g min-I and that to the left 1.6 f 0.8, there being no statistically significant difference between the two.
Limb bloodflow
Blood-flow measurements appear to be a relevant method for assessing patients with suspected peripheral vascular disease since they give a direct measure of the reduction in nutrient blood flow, which is responsible for the progression of disability and even, ultimately, to the loss of the limb.
Kety (1949) was one of the 6rst to study this by monitoring the clearance of radioactive sodium injected into the calf muscle. The clearance rate followed his predicted exponential model. He also demonstrated changes in muscle blood flow with reactive hyperaemia and after exercise. However, tissue:blood exchange of %Na is diffusion limited at high bloodflow levels (Lassen 1964).
Lassen's group has used an intramuscular injection of 133Xe to study flow (Lassen et a1 1964, 1965). They gave two intramuscular injections of 133Xe dissolved in saline, one in the tibialis muscle and the other in the gastrocnemius, measuring the rate of clearance from each site with a separate probe detector. The single-exponential technique was used to measure flow. In the resting state, no difference in calf blood flow was observed between normal patients and those with peripheral vascular diseases, the average of 25 observations being 1.6 ml/lOO g mi&. Flow measured in the same patients by plethysmography was found to be higher (3 ml/IOO g min-'). However, differences were found between normal and peripheral vascular occlusion after muscle exercise during ischaemia, the latter having an average flow of 13.2 ml/lOO g min-' compared with the normal value of 39.9 ml/lOO g min-'. There were also differences between flow in the two muscles, that from the tibialis being, on average, over 50% higher. Lindberg (1966) demonstrated that flow depended on the length of the period of ischaemia and exercise, while Lassen and Holstein (1974) investigated the presence of occlusive vascular lesions.
Clearly, diagnostic information is only available after a physiological challenge. Parkin et a1 (1986, 1987) suggested a test that measured blood flow after ischaemia, which was both simple to perform and readily reproducible. The patient is positioned supine with the lower legs and feet over the gamma camera. The circulation below the knees is isolated by inflated cuffs. 99Tcm red blood cells or human serum albumin is injected into an antecubital vein and three minutes allowed for mixing with blood. Towards the end of this period a blood sample is taken. The cuffs are released and a series of 1 s images taken. The time activity curves for the two legs are generated. The slope of the initial linear phase of this curve, when labelled blood is entering the leg displacing unlabelled blood, is proportional to blood flow. The blood sample gives the specific activity of the tracer and is used to calibrate the curve. Limb volume is measuring the amount of water displaced when the limb is immersed.
Normal volunteers were found to have a mean flow of 15.6 i 3.5 m1/100 g min-' (Parkin et a1 1991) ; this compares with 14.1 i 5.9 m1/100 g min-' found by Lindberg (1966), after a similar period of ischaemia.
Liver bloodjlow
In liver disease a number of portal collaterals develop, the resulting decrease in hepatic blood flow being one cause of hepatic failure. There has been considerable interest in recent years in obtaining a measure of hepatic blood flow in the hope of obtaining a diagnostic tool for liver disease and, in particular, for detecting occult liver metastases.
The use of the rate of disappearance of colloidal particles from the blood stream has been studied as a measure of liver blood flow for many years (see e.g. Vetter et al 1954).
The difficulty encountered was that the results depended on the percentage of material extracted by the liver Kuppfer cells which, in tum, depended on the quality of the colloidal preparation. Shaldon and colleagues (1961) reported studies with colloidal heat-denatured human serum albumin labelled with 13'1 in which particle size could be controlled. Blood flow was measured from the clearance of plasma-bound colloid using arterial and hepatic-vein blood samples taken simultaneously for 3 0 6 0 min post-injection. ?Lvo exponentials were identified in the plasma activity clearance curve, the slower one, predominant after about 10 min, being associated with the clearance of small particles by the extrahepatic RES. By subtracting the slope of this slow component from that of the initial fast one, the corrected clearance curve for colloid by the liver was calculated. Extrapolating the clearance curve back to zero time gives the initial concentration of activity; the ratio of the injected activity to this value gives the volume of distribution of the colloid. The product of volume and clearance constant will give the hepatic blood flow, in millilitres per minute.
If the hepatic extraction of the colloid is less than loo%, the blood flow as calculated above will be less than the true value. This flow has been called the minimal hepatic blood flow (MHBF): dividing it by the extraction factor, E , yields the total hepatic blood flow (THBF). However, to calculate E the activity clearance rate in hepatic venous plasma must be measured, so introducing an additional complication into the measurement process.
Shaldon et a1 found good correlation between THBF and flow measured with indocyanine green. In the control group the MHBF was 1516 f 362 ml min-', while THBF was 1663 i 478 ml min-'. Thus for patients without liver disease the simpler peripheralsampling method gives a flow value only about 10% lower than the total one. In patients with cirrhosis and a patent portal vein the extraction efficiency drops and the difference between MHBF and THBF becomes greater. However, Shaldon et a1 suggested that MHBF was a measure of the functional blood supply to the liver.
Shiomi et a1 (1991) used '33Xe in saline to measure hepatic blood flow by injecting it into the upper part of the rectum via a catheter. It was assumed that the activity appearing in the liver arrived through the portal vein, the rest being excreted via the lungs. While normal patients were not studied, a flow of 75 m1/100 g min-' was found in patients with cirrhosis and 128 m1/100 g min-' in those with chronic hepatitis. The same group also used 9gTcm pertechnetate per-rectally, in this case developing a shunt index to calculate the percentage going to the heart rather than the liver (Shiomi et a1 1988) . Positron-labelled tracers have also been used to study hepatic blood flow. Chen and colleagues (1991) used a two-compartment model to describe the uptake of ammonia in the liver for the first 90 s following intravenous bolus injection. The two compartments consisted of a free space comprising vascular and free ammonia and a trapped space for ammonia bound in tissue. The arterial input function was determined from the activity in the mid-left ventricle. In eight normal volunteers the regional hepatic blood flow was found to be 26&7 m1/100 g min-' and the extraction efficiency estimated to be greater than 90%.
Bone bloodflow
The 133Xenon washout technique has been used to study bone blood flow by Lahtinen and colleagues (1979, 1981 ). An intravenous injection of 40 MBq of '33Xe in physiological saline was given and activity monitored by a scintillation probe over the greater trochanter of the femur. The curve for the first 30 min of washout was analysed as two compartments. The first rapid-clearance phase was associated with clearance from red marrow while the siower clearance represented elimination f?om non-haematopoietic tissue, i.e., solid bone and intraosseous fat. Correction for recirculation was made using a measurement of activity in expired air. Between the ages of 20 and 55 the mean blood flow was constant at 8.3 i 1.4 mI/lOO g min-', but it decreased after 55 years of age. The resulting total skeletal blood flow corresponded to 14.7% cardiac output. The red-marrow flow decreased linearly with age, while non-haematopoeitic flow behaved like mean bone blood flow. This technique has been used to study flow in patients w i t h chronic granulocytic leukaemia and primary myelofibrosis &ahtinen eta1 1982b) and polycythemia vera (Lahtinen eta1 1982a).
Simon and colleagues (1977) describe results from a comparison of 99Tcm pertechnetate and I3II iodo-antipyrine to measure blood flow in necrotic femoral heads. The radiophannaceuticals were injected directly into the trochanter region. They found good agreement between the two tracers and suggested that pertechnetate might be an excellent tracer for measuring bone blood flow. However, as only low flow values were encountered in this group of patients, then the pertechnetate ion, which would normally be diffusion limited, may well reach diffusion equilibrium and so behave as a flow-limited tracer (Lassen and Holstein 1974) .
Van Dyke et d (1965, 1971) were the first to describe the use of the positron-emitting lafluorine to study bone blood flow. Using a simple compartmental model they calculated normal bone blood flow as 3.3% cardiac output, corresponding to 2.4 ml/lOO gmin-I. This increased to 7.85% cardiac output in patients with myelofibrosis.
Detailed studies of the kinetics of "F have been made by Wootton and colleagues. In experiments on rabbits they found that the first-pass extraction ratio of 18F was approximately 1.0 (Wootton 1974). They then determined bone blood flow based on a more sophisticated model than that used previously (wootton et al 1976) . In this the tracer moves from the blood pool either into a combined extracellular fluid (Em)/bone pool or is excreted by the kidney. A two-way flow between the blood pool and both the E m and bone pools is assumed. By measuring the time course of activity in the blood and urine, the fraction of the tracer dose in the combined EcFibone pool can be cdculated. Deconvolution of the blood-pooI input function from the bondEm retention function gives the retention response of this combined pool. The initial value of this function gives the transfer rate of tracer into the pool before back flow of tracer can occur. To calculate the fraction of this combined pool attributable to ECF, "Cr EDTA is administered simultaneously with "F. Assuming that EDTA is distributed in the ECF pool in the same way as "F, but is not taken up by bone, the clearance of l8F to the bone pool can then be calculated. From this, and assuming an extraction ratio of loo%, bone blood flow can be found.
In eight normal volunteers the mean bone blood flow was 4 m1/100 g min-', while in six patients with Paget's disease it was shown to be significantly elevated. The precision of the technique was estimated to be 16.4%.
Charkes eta1 (1978) suggested that the EcFhone pool should be considered as consisting of an Emhone and an ECFlnon-bone compartment. Analysing the data of nine existing studies they calculated normal bone blood flow as 11.7 f 0.7 m1/100 g m i d , significantly higher than that reported by other workers.
Bonemarrow blood flow has been measured with HZ "0, using the C1502 inhalation technique (Martiat et a1 1987) . Measurements taken over the posterior iliac crest in normal volunteers gave a flow of 10 4 3 m1/100 cm3 m i d . Flow was found to be elevated in patients with polycythaemia vera, chronic granulocytic leukaemia, and myelofibrosis.
Ashcrofi and colleagues (1992) have used injected H2I5O to study changes in bone blood flow in patients with a tibial fracture.
Bloodfiw in other organs
4.8.1. Spleen. The xenon clearance technique has been used to study splenic blood flow by Huchzermeyer et a1 (1977) . The gas was administered by inhalation and the expired gas sampled to estimate arterial blood concentration. In 22 normal patients blood flow was 109 f 4 ml/lOO g mi&, equivalent to a total flow of about 170 ml min-'. In six patients with chronic hepatitis and fatty degeneration, and five with cirrhosis but no splenomegaly, a significant reduction in blood flow was found.
Using 99Tcm human-serum-albumin microspheres, Crean et a1 (1986) gave a flow of 214 f 113 ml min-', representing 5.2 f 1.6% cardiac output, while the mean transit time was 36.9 f 4.6 s. Selwyn et a1 (1986), using PET imaging of "C microspheres, found the peak splenic flow to be 1 4 f f 7 7 ml/lOO g min-' in patients with known myocardial infarction. (15)), the presence of fat, resulting in slow washout of a small proportion of the inert gas, making measurement of the complete clearance time unacceptably long. They differentiated between total flow and flow to the superficial muscular layer by measuring clearance using the gamma-ray emissions for the former and the weakly penetrating beta particles for the latter.
Measurements of colonic blood flow were made on 55 patients, all of whom were being laparotomized (Hulten et a1 1976a) . Total colonic blood flow was 1 8 f 2 ml/lOO g m i d and that in the muscularis 1 I f 1 ml/lOO g min-'. Knowing the relative weights of the mucosasubmucosa and muscularis, the blood flow of the mucosa-submucosa was calculated to be 28 -+ 5 m1/100 g min-'. Duect measurement of coIonic blood flow by collection of blood draining from the colonic section gave a total blood flow of 16 -+ 2 ml/IOO g min-', not significantly different from the value obtained with the tracer. The higher blood flow to the mucosa is consistent with the absorption and secretion processes located there.
This group also used the same technique to measure flow in the small intestine (Hulten et ol 1976b). They found average flow values of 40 ml/lOO g min-', being slightly higher in the jejunum than the ileum. About 75% of the total blood flow was diverted to the mucosa-submucosa, where blood flow per unit weight of tissue was two to three times that in the intestine as a whole.
Gastric-blood-flow measurements were made on 20 patients being operated on for gall- Schwxz and Graham (1991) and Mualdi et 01 (1989, 1992 ) used a dual-isotopeinjection approach. In Mualdi's technique, a direct bolus injection of '33Xe is made into the corpora cavemosum together with an intraveous injection of 99Tcm-labelled red blood cells.
Assuming a single compamnent model and that the venous recirculation time is small, then venous flow, fv. and arterial flow, fa, are linked by the equation
where V is the penile volume, Q the activity in the penis, B the fraction of recirculating venous blood, and I the partition coefficient, for which a value of unity was assumed.
For the red blood cells the concentration of activity in the blood remains constant and is identical in the arterial and venous blood, so the Kety equation becomes (25) From these two equations, both arterial and venous flow can be calculated in terms of dQ/dt and dV/dt, the xenon-clearance curve, measured over the whole of the penis, giving the former and the red blood cells the latter. Miraldi et a1 studied the effect of vasodilator. In normal volunteers, the peak arterial blood flow was 13 f 1.28 ml min-' and the venous 4.25 f. 1.17; patients with vascular leakage had a significantly increased peak venous flow, while those with arterial leakage had a significantly lower arterial flow. fa = fv + dV/dt. 4.8.4. Skin. Skin blood flow has been thoroughly studied by Sejersen (1971) . The principal problem was to achieve administration of the tracer atraumatically to avoid the hyperaemic effect of a local injection. He describes a technique for epicutaneous application of '33Xe involving the introduction of xenon, either as a gas or a saline solution, into a chamber formed by a Mylar membrane placed over the surface of the skin. A biexponential washout curve is produced, representing flow associated with the cutaneous and subcutaneous tissue. For tissue in the crus, blood flow in cutaneous tissue was found to be 5.7 f 1.3 m1/100 g min-', while in subcutaneous tissue it was 3 f 1.6.
A comparative study with laser Doppler flowmetry (Englebart et ul 1988) showed that the xenon technique provided the more accurate information as it demonstrated blood-flow changes in nutritional vessels while the laser technique measured total skin blood flow including non-capillary vessels.
In the same paper Sejersen also proposes that a combined hi~tamine-'~~Xe injection could be given. This would result in a hyperaemic reaction; if the blood supply were normal the initial clearance rate would be higher and the measurement of cutaneous blood flow could be completed in a few minutes. This technique was used by Kastrup etal (1987) to study changes in vascular stiffness consequent to diabetic microangiography.
Discussion
Radiotracers have been used for nearly 70 years to study blood flow; this is itself an indication of the versatility of nuclear medicine where the development of a new tracer can open up an entirely new area to study.
From the point of view of measurement accuracy, PET is undoubtedly the technique of choice. Not only does it offer instnunentation most suited to quantitative measurement from images but the available tracers, in particular Hz ISO, are more physiologically realistic and this makes modelling of tracer kinetics easier. However, it seems unlikely that, in the near future, this technique will be available in any but the major centres. While SPECT is now available in nearly all nuclear-medicine departments, the problem of correcting for tissue attenuation limits its accuracy.
The potential accuracy of blood-flow measurement depends not only on the performance of the instrumentation but also upon the validity of the models used to describe the dynamics of the tracer. In this respect attention must be drawn to the problems associated with the use of the partition coefficient, A. The effect of the accuracy of A on the calculated flow depends upon the technique used. Clearance techniques are particularly sensitive to it: in the initialslope technique of equation (8) errors in A will produce an equal error in flow, while the autoradiographic technique is relatively insensitive to error in A. In contrast, the integratedprojection techniques avoid the use of A. The difficulties with A arise in two ways. Firstly, when there is inhomogeneity in the organ's tissue, the relatively poor spatial resolution of imaging devices may unavoidably result in flow being measured from a mixture of tissue of different flow rates. This is a particular problem in the brain where grey and white matter cannot be clearly discriminated. Secondly, there are many circumstances where the standard value for A is expected to be inappropriate. For example changes in blood water content due to variation in haematocrit may affect the value of A for water; neonatal or oedematous brain will have a different A from normal adult tissue. These problems have been discussed by Herscovitch and Raichle (1985) .
From the practising nuclear-medicine clinician's viewpoint, relatively few of the techniques described in this review have been adopted as routine practice in the UK although 
